Series B - Ratio Therapeutics
Investment Firm
Overview
Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
Announced Date
Jan 17, 2024
Closed on Date
Jan 17, 2024
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
Round Details and Background
Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B
Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 01, 2023 |  Series A - Ratio Therapeutics | 2 | - | 20.0M |
| Jun 20, 2022 | Seed Round - Ratio Therapeutics | - | 20.0M | |
| Jan 17, 2024 | Series B - Ratio Therapeutics | 5 | - | 50.0M |
Recent Activity
There is no recent news or activity for this profile.